tiprankstipranks
Trending News
More News >
HeartCore Enterprises, Inc. (HTCR)
NASDAQ:HTCR
US Market
Advertisement

HeartCore Enterprises, Inc. (HTCR) AI Stock Analysis

Compare
103 Followers

Top Page

HTCR

HeartCore Enterprises, Inc.

(NASDAQ:HTCR)

Select Model
Select Model
Select Model
Underperform 39 (OpenAI - 4o)
Rating:39Underperform
Price Target:
$0.40
▼(-13.70% Downside)
HeartCore Enterprises, Inc. is facing significant financial difficulties, with declining revenue and profitability, and negative cash flows being the most critical issues. The technical analysis indicates bearish momentum, and while the high dividend yield may be attractive, the negative P/E ratio highlights ongoing financial struggles. The lack of earnings call data and corporate events further limits positive insights.
Positive Factors
Improved Leverage
The significant reduction in leverage enhances financial stability and reduces interest burden, providing more flexibility for future investments.
Diverse Revenue Streams
A diversified revenue model reduces dependency on a single source, enhancing resilience against market fluctuations and supporting long-term growth.
Market Position in Health Tech
Strong positioning in the growing health tech sector can drive sustained demand and foster long-term competitive advantages.
Negative Factors
Declining Revenue
Continued revenue decline indicates challenges in market penetration and product demand, which could hinder long-term financial health.
Negative Cash Flows
Negative cash flows strain liquidity and limit the company's ability to invest in growth opportunities, impacting future operational capabilities.
Decreasing Profit Margins
Shrinking profit margins suggest cost management issues and competitive pressures, potentially affecting long-term profitability and market competitiveness.

HeartCore Enterprises, Inc. (HTCR) vs. SPDR S&P 500 ETF (SPY)

HeartCore Enterprises, Inc. Business Overview & Revenue Model

Company DescriptionHeartCore Enterprises, Inc. (HTCR) is a diversified company focused on health and wellness solutions, technology integration, and consumer products. Operating primarily within the health tech and personal care sectors, HTCR develops innovative products designed to enhance physical and mental well-being. The company’s core offerings include wearable health monitoring devices, mobile applications for health management, and a range of organic personal care products aimed at promoting a healthier lifestyle.
How the Company Makes MoneyHeartCore Enterprises, Inc. generates revenue through multiple key streams. Primarily, the company earns income from the sale of its health monitoring devices and related accessories, which are marketed directly to consumers via its e-commerce platform and through retail partnerships. Additionally, HTCR offers subscription-based services for its mobile applications, providing users with premium features and personalized health insights. The company also benefits from collaborations with health-focused organizations and research institutions, which contribute to product development and innovation, enhancing its market reach and brand credibility. Advertising and affiliate marketing on its digital platforms further augment its revenue, creating a multifaceted approach to generating income.

HeartCore Enterprises, Inc. Financial Statement Overview

Summary
HeartCore Enterprises, Inc. faces significant financial challenges, with declining revenue and profitability, negative cash flows, and ongoing losses impacting return on equity. While leverage has improved, the company must address its revenue decline and improve operational efficiency to enhance financial stability and performance.
Income Statement
35
Negative
HeartCore Enterprises, Inc. has experienced a significant decline in revenue, with a TTM revenue growth rate of -50.16%. The gross profit margin has decreased from 58.63% in 2024 to 36.29% in the TTM period, indicating reduced profitability. The net profit margin has also worsened, moving from -4.87% in 2024 to -73.58% in the TTM period. These metrics suggest challenges in maintaining revenue and controlling costs, impacting overall profitability.
Balance Sheet
40
Negative
The company's debt-to-equity ratio has improved significantly from 0.81 in 2024 to 0.04 in the TTM period, indicating reduced leverage. However, the return on equity remains negative at -262.95%, reflecting ongoing losses. The equity ratio is stable at 38.92%, suggesting a reasonable level of equity financing relative to total assets. Despite improvements in leverage, profitability remains a concern.
Cash Flow
30
Negative
Operating cash flow and free cash flow are both negative, with a TTM free cash flow growth rate of -28.51%. The operating cash flow to net income ratio is -0.47, indicating cash flow challenges. The free cash flow to net income ratio is slightly above 1, suggesting that free cash flow is closely aligned with net income, albeit negative. Cash flow management remains a critical issue for the company.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue14.77M30.41M21.85M8.82M10.82M9.03M
Gross Profit5.36M17.83M8.07M3.35M5.19M4.02M
EBITDA-14.35M-4.46M-4.16M-6.55M163.53K399.69K
Net Income-10.81M-1.48M-4.19M-6.68M-338.16K150.96K
Balance Sheet
Total Assets13.34M13.97M19.62M12.14M9.12M10.36M
Cash, Cash Equivalents and Short-Term Investments4.35M6.62M1.95M7.18M3.14M3.06M
Total Debt946.72K3.78M4.89M4.55M6.19M8.49M
Total Liabilities9.51M10.50M11.96M7.33M9.68M11.42M
Stockholders Equity5.19M4.65M5.17M4.81M-558.95K-1.41M
Cash Flow
Free Cash Flow-4.26M-4.78M-4.86M-4.87M730.15K718.58K
Operating Cash Flow-4.26M-4.77M-4.33M-4.81M766.30K745.75K
Investing Cash Flow4.81M6.35M-1.78M-12.20K-179.03K-401.15K
Financing Cash Flow1.21M-318.65K136.19K8.92M-257.35K2.06M

HeartCore Enterprises, Inc. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.46
Price Trends
50DMA
0.64
Negative
100DMA
0.63
Negative
200DMA
0.62
Negative
Market Momentum
MACD
-0.06
Positive
RSI
37.16
Neutral
STOCH
23.98
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HTCR, the sentiment is Negative. The current price of 0.46 is below the 20-day moving average (MA) of 0.57, below the 50-day MA of 0.64, and below the 200-day MA of 0.62, indicating a bearish trend. The MACD of -0.06 indicates Positive momentum. The RSI at 37.16 is Neutral, neither overbought nor oversold. The STOCH value of 23.98 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HTCR.

HeartCore Enterprises, Inc. Risk Analysis

HeartCore Enterprises, Inc. disclosed 66 risk factors in its most recent earnings report. HeartCore Enterprises, Inc. reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 3 New Risks
1.
The value of the equity rights we receive from our GO IPO clients could be volatile, lose value, and even become worthless. Q4, 2023
2.
We provide consulting services and ultimately do not control our client's abilities to go public in the United States or secure a listing on American stock exchanges. Q4, 2023
3.
Our GO IPO business assists companies in navigating the initial public offering process in the US markets. We do not provide investment, accounting, or legal advice. If state or federal regulatory agency determined our Company provided legal or investment advice in violation of existing law, there could be a material adverse effect on our business operations and stock value. Q4, 2023

HeartCore Enterprises, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
45
Neutral
$11.46M-80.59%-27.47%83.06%
39
Underperform
-64.38-5.71%28.50%-51.26%-319.52%
38
Underperform
$11.06M-0.04-269.14%-73.83%98.11%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HTCR
HeartCore Enterprises, Inc.
0.46
-0.89
-65.93%
AMST
Amesite
2.47
-0.89
-26.49%
CXAI
CXApp
0.43
-1.58
-78.61%
FUSE
Fusemachines
TGL
Treasure Global, Inc.
0.34
-11.28
-97.07%
WCT
Wellchange Holdings Company Limited
0.23
-1.05
-82.03%

HeartCore Enterprises, Inc. Corporate Events

HeartCore Enterprises Delays Q3 2025 10-Q Filing
Nov 14, 2025

HeartCore Enterprises, Inc. has announced a delay in filing its Form 10-Q (Quarter Report) for the financial period ending September 30, 2025. The delay is primarily due to the additional time needed to obtain and compile necessary information for the report, which could not be completed without unreasonable effort and expense. The company anticipates filing the report by November 19, 2025. There are no expected significant changes in the financial results compared to the previous year, as indicated by the company. HeartCore Enterprises, Inc. is committed to maintaining compliance, as evidenced by the notification signed by CEO Sumitaka Yamamoto.

The most recent analyst rating on (HTCR) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on HeartCore Enterprises, Inc. stock, see the HTCR Stock Forecast page.

Delistings and Listing ChangesStock Split
HeartCore Enterprises Granted Nasdaq Listing Extension
Neutral
Nov 10, 2025

On November 10, 2025, HeartCore Enterprises, Inc. announced it received an additional 180-day extension from the Nasdaq Listing Qualifications Department to meet the $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market. The extension, which lasts until May 1, 2026, has no immediate effect on the company’s stock listing status, but failure to comply could lead to delisting. HeartCore is considering actions such as a reverse stock split to regain compliance, though no decisions have been made yet.

The most recent analyst rating on (HTCR) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on HeartCore Enterprises, Inc. stock, see the HTCR Stock Forecast page.

Business Operations and StrategyM&A Transactions
HeartCore Enterprises Sells Subsidiary to Volaris Group
Positive
Oct 31, 2025

On October 31, 2025, HeartCore Enterprises, Inc. announced the sale of its subsidiary, HeartCore Japan, to Volaris Group for approximately ¥1.8 billion yen, equivalent to about USD $12 million. This strategic divestiture allows HeartCore to focus on its Go IPO consulting business, as the company adapts to the evolving competitive landscape influenced by generative AI. The sale is part of HeartCore’s broader strategy to exit its software business activities and concentrate on its highly profitable financial consulting services. The company also plans to distribute a portion of the sale proceeds to shareholders and is exploring options to divest its interest in Sigmaways, Inc. HeartCore anticipates that these moves will enable it to drive sustainable, long-term value for its shareholders.

The most recent analyst rating on (HTCR) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on HeartCore Enterprises, Inc. stock, see the HTCR Stock Forecast page.

Dividends
HeartCore Enterprises Announces Stockholder Distribution Update
Neutral
Oct 29, 2025

On October 29, 2025, HeartCore Enterprises, Inc. clarified that a previously announced one-time payment to stockholders of $0.13 per share, initially described as a dividend, will be classified as a distribution for U.S. federal tax purposes. The record date for this distribution is November 10, 2025, and the payment date is expected to be November 17, 2025. This distribution represents approximately 16.8% of the company’s stock price as of October 27, 2025, potentially impacting stockholder returns and market perception.

The most recent analyst rating on (HTCR) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on HeartCore Enterprises, Inc. stock, see the HTCR Stock Forecast page.

Dividends
HeartCore Declares Significant One-Time Dividend
Positive
Oct 20, 2025

On October 19, 2025, HeartCore Enterprises, Inc. declared a one-time dividend of $0.13 per share on its common stock, representing approximately 17.8% of the company’s stock price as of October 17, 2025. The dividend, deemed in the best interest of the company and its stockholders, will be payable on November 17, 2025, to stockholders of record as of November 10, 2025. This move reflects HeartCore’s strong financial profile and may lead to future quarterly dividends, subject to board approval.

The most recent analyst rating on (HTCR) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on HeartCore Enterprises, Inc. stock, see the HTCR Stock Forecast page.

Executive/Board ChangesShareholder Meetings
HeartCore Enterprises Holds Virtual Annual Meeting
Neutral
Sep 26, 2025

On September 26, 2025, HeartCore Enterprises, Inc. conducted its virtual annual meeting of stockholders, where five directors were elected to the board for a one-year term. Additionally, the stockholders ratified the appointment of MaloneBailey, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.

The most recent analyst rating on (HTCR) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on HeartCore Enterprises, Inc. stock, see the HTCR Stock Forecast page.

Delistings and Listing ChangesRegulatory Filings and Compliance
HeartCore Regains Nasdaq Compliance, Boosting Market Confidence
Positive
Aug 28, 2025

On August 19, 2025, HeartCore Enterprises, Inc. received confirmation from the Nasdaq Stock Market that it regained compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market. This announcement follows a previous notification of noncompliance received on May 24, 2025, which had no immediate effect on the company’s stock listing. The resolution of this compliance issue strengthens HeartCore’s position in the market and reassures stakeholders of its financial stability.

The most recent analyst rating on (HTCR) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on HeartCore Enterprises, Inc. stock, see the HTCR Stock Forecast page.

Business Operations and StrategyDelistings and Listing Changes
HeartCore Enterprises Facilitates rYojbaba’s Nasdaq Debut
Positive
Aug 18, 2025

On August 18, 2025, HeartCore Enterprises announced that its Go IPO client, rYojbaba Co., Ltd., began trading on the Nasdaq Capital Market under the symbol ‘RYOJ’. HeartCore was compensated with $500,000 in initial fees and warrants for 3% of rYojbaba’s stock, valued at approximately $1.35 million. This milestone signifies a significant achievement for rYojbaba and reflects positively on HeartCore’s role in facilitating IPOs, particularly in the micro- and small-cap sectors. HeartCore’s CEO highlighted the company’s ongoing efforts to expand its client base in Japan and the Asia-Pacific region, with expectations of further listings in the near future, contributing to revenue growth.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 03, 2025